ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AHG vs PG // ALTMAN Z-SCORE & DEBT/EQUITY

Akso Health Group ADS (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: AHG 0 — PG 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHG VS. PG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AHG PG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -0.10% 51.20% -51.30 PG /gross-margins <GO>
Return on Invested Capital (ROIC) — 25.40% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 16.2x — TIE /valuation <GO>
Free Cash Flow Yield -1.12% 3.77% -4.89 PG /fcf-yield <GO>
Operating Margin -60.00% 24.30% -84.30 PG /operating-margins <GO>
Net Profit Margin -60.00% 19.00% -79.00 PG /net-margins <GO>
Revenue Growth (YoY) -6.40% 0.30% -6.70 PG /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.65% -2.65 PG /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 5.59 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 PG /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.6 60.3 -2.70 PG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.87 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 21.7x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.14B $372.21B -$371.07B PG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AHG REV PG REV AHG GROSS % PG GROSS % AHG FCF PG FCF
FY 2025 $13.8M $84.28B -0.1% 51.2% -$12.8M $14.04B
FY 2024 $14.8M $84.04B -1.9% 51.4% $1.0M $16.52B
FY 2023 $2.4M $82.01B — — $1.4M $13.16B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHG // BETA —
PG // BETA 0.87